We have recently reported that elevated levels of PRMT5 up‐regulates WNT/β‐CATENIN proliferative signalling through transcriptional repression of pathway antagonists, AXIN2 and WIF1, in three different types of non‐Hodgkin’s lymphoma cells.37 This evidence concerns the gene AXIN2 and Hodgkins lymphoma.